SCHEMBL7950686

SCHEMBL7950686

C=C(Nc1nn(CCC)c2nc(-c3cnn4ccccc34)c(F)cc12)C1CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.38
L3MBTL1 Q9Y468 5/20 0.38
ATM Q13315 4/20 0.38
KMT2A Q03164 3/20 0.37
MEN1 O00255 2/20 0.37
MAPK1 P28482 2/20 0.37
ALDH1A1 P00352 7/20 0.37
HPGD P15428 4/20 0.37
CASP1 P29466 3/20 0.37
CASP7 P55210 2/20 0.37
HSD17B10 Q99714 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
HTT P42858 2/20 0.36
CYP1A2 P05177 1/20 0.36
POLB P06746 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
MAPT P10636 2/20 0.36
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8043772 0.97 KDM4E (0.38) KDM4EL3MBTL1ATMKMT2AMEN1
SCHEMBL7952511 0.84 ALDH1A1 (0.50) KDM4EL3MBTL1ATMKMT2AMEN1
SCHEMBL8049613 0.81 ATM (0.42) KDM4EL3MBTL1ATMKMT2AMEN1
SCHEMBL13099782 0.81 CCNT1 (0.39) JAK2JAK1JAK3PIK3CBIGF1R
SCHEMBL7942597 0.80 CCNT1 (0.40) KMT2AMEN1CASP1HSD17B10CYP1A2
SCHEMBL8041792 0.79 PIK3CB (0.43) MAPK1CYP3A4JAK2JAK1PIK3CB
SCHEMBL7954528 0.78 CCNT1 (0.41) KDM4EL3MBTL1ATMKMT2AMEN1
SCHEMBL13099796 0.78 ALDH1A1 (0.49) KDM4EL3MBTL1ATMKMT2AMEN1
SCHEMBL8049619 0.78 KDM4E (0.39) KDM4EL3MBTL1ATMKMT2AMEN1
SCHEMBL13099812 0.78 PIK3CB (0.38) KDM4EL3MBTL1ATMMAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010027114-A1 USE OF PYRAZOLE-PYRIDINE DERIVATIVES AND ITS SALTS FOR TREATING OR REVENTIN OSTEOPOROSIS CHOONGWAE PHARMA CORPORATION (KR) 2010-03-11 WO disclosed
WO-2009038385-A2 NOVEL COMPOUNDS HAVING INDAZOLE FRAMEWORKS, METHODS FOR PREPARING THE SAME AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHOONGWAE PHARMA CORPORATION (KR) 2009-03-26 WO disclosed